InvestorsHub Logo
Followers 17
Posts 3817
Boards Moderated 4
Alias Born 08/23/2022

Re: None

Tuesday, 02/06/2024 11:28:01 AM

Tuesday, February 06, 2024 11:28:01 AM

Post# of 45863
$BCTX BriaCell announces GMP manufacturing of Bria-Pros+, a personalized cellular cancer vaccine for prostate cancer. Bria-Pros+ activates multiple immune cells to fight tumors. Pre-clinical data shows promising results. https://www.globenewswire.com/news-release/2024/2/6/2824344/0/en/Breaking-Ground-in-Prostate-Cancer-BriaCell-Announces-Lead-Prostate-Cancer-Candidate-Bria-Pros-Initiates-GMP-Manufacturing.html





Major News Alert: BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) Breaking Ground in Prostate Cancer: Major Milestone with BriaCell’s Off-The-Shelf Personalized Cellular Cancer Vaccines #cancer #immunotherapy $BCTX

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.